Cornerstone Planning Group LLC Charles River Laboratories International, Inc. Transaction History
Cornerstone Planning Group LLC
- $418 Billion
- Q1 2025
A detailed history of Cornerstone Planning Group LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 28 shares of CRL stock, worth $3,888. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28
Previous 13
115.38%
Holding current value
$3,888
Previous $2.16 Million
41.56%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CRL
# of Institutions
654Shares Held
55.9MCall Options Held
691KPut Options Held
810K-
Vanguard Group Inc Valley Forge, PA6.11MShares$848 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$707 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$595 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$332 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$271 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.06B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...